Piden fabricar genéricos en periodo de extensión

El presidente de la EGA considera que actualmente la industria europea de genéricos está “atada de manos”.

Impact of extending the duration of regulatory data… 14 February 2024 In the context of the new EU pharmaceutical legislation, this…
Note for the rapporteurs/shadow rapporteurs of the EU… 7 December 2023 In the context of the new EU pharmaceutical legislation, this…
IQVIA - Assessing the Biosimilar Void 30 October 2023 While biosimilar competition in Europe has played a vital role…
Review of the SPC Manufacturing Waiver: a First Industry… 13 June 2023 The Supplementary Protection Certificate (SPC) is a sui generis protection…